Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ceribell (CBLL) Cash & Equivalents (2023 - 2025)

Ceribell's Cash & Equivalents history spans 3 years, with the latest figure at $40.5 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 79.18% year-over-year to $40.5 million; the TTM value through Dec 2025 reached $40.5 million, down 79.18%, while the annual FY2025 figure was $40.5 million, 79.18% down from the prior year.
  • Cash & Equivalents reached $40.5 million in Q4 2025 per CBLL's latest filing, up from $23.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $194.4 million in Q4 2024 to a low of $14.1 million in Q3 2024.
  • Average Cash & Equivalents over 3 years is $71.5 million, with a median of $40.1 million recorded in 2025.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 463.47% in 2024, then crashed 79.18% in 2025.
  • A 3-year view of Cash & Equivalents shows it stood at $34.5 million in 2023, then surged by 463.47% to $194.4 million in 2024, then plummeted by 79.18% to $40.5 million in 2025.
  • Per Business Quant, the three most recent readings for CBLL's Cash & Equivalents are $40.5 million (Q4 2025), $23.7 million (Q3 2025), and $40.1 million (Q2 2025).